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Although uridine-rich small nuclear RNAs (U-
snRNAs) are essential for pre-mRNA splicing, little
is known regarding their function in the regulation
of alternative splicing or of the biological conse-
quences of their dysfunction in mammals. Here, we
demonstrate that mutation of Rnu2-8, one of the
mouse multicopy U2 snRNA genes, causes ataxia
and neurodegeneration. Coincident with the
observed pathology, the level of mutant U2 RNAs
was highest in the cerebellum and increased after
granule neuron maturation. Furthermore, neuron
loss was strongly dependent on the dosage of
mutant and wild-type snRNA genes. Comprehensive
transcriptome analysis identified a group of alterna-
tive splicing events, including the splicing of small
introns, which were disrupted in the mutant cere-
bellum. Our results suggest that the expression of
mammalian U2 snRNA genes, previously presumed
to be ubiquitous, is spatially and temporally regu-
lated, and dysfunction of a single U2 snRNA causes
neuron degeneration through distortion of pre-
mRNA splicing.
INTRODUCTION
Splicing of pre-mRNAs is performed by the spliceosome
machinery consisting of numerous proteins and five small
nuclear RNAs (snRNAs) (Wahl et al., 2009). Assembly of the
major spliceosome, responsible for splicing of over 90% of
human pre-mRNAs, begins with the recruitment of U1 snRNPs
(small nuclear ribonucleoprotein particles) to the pre-mRNA 50
exon/intron junction via base pairing of the U1 snRNA with the
splice site. U2 snRNPs subsequently bind to the pre-mRNA
branchpoint sequence (BPS) near the 30 intron boundary, also
in part via base-pairing interactions. Further remodeling of the
spliceosome results in the recruitment of additional snRNPs,
including U6 snRNPs that will replace U1 snRNPs at 50 pre-
mRNA splice sites. Base pairing of U6 with U2 snRNAs juxta-
poses the 50 splice site and the BPS, the reactants of the first296 Cell 148, 296–308, January 20, 2012 ª2012 Elsevier Inc.transesterification reaction. Thus, recognition and removal of
introns and subsequent exon ligation depend in part on the
dynamic base pairing of snRNAs with pre-mRNAs and with
each other.
Given the critical importance of pre-mRNA splicing to the
regulation of gene expression and proteome diversity, it follows
that mutations in RNA-processing proteins that may influence
pre-mRNA splicing cause human disease (Cooper et al., 2009;
Licatalosi and Darnell, 2006). Indeed, dominant mutations in
multiple ubiquitously expressed protein components of the
U4/U5/U6 tri-snRNP cause retinitis pigmentosa (Mordes et al.,
2006). Mutations in the SMN1 (survival of motor neuron 1)
gene, which encodes a protein essential for U snRNP biogen-
esis, cause motor neuron degeneration in patients with spinal
muscular atrophy (SMA) (Lefebvre et al., 1995). Although SMN
is ubiquitously expressed, alterations in the levels of individual
snRNAs and numerous aberrant transcripts were observed in
a tissue-specific fashion in SMN-deficient mice (Zhang et al.,
2008). Mutations in genes encoding the ubiquitously expressed
DNA/RNA-binding proteins, TDP-43 and FUS/TLS, are associ-
ated with some cases of familial and sporadic amyotrophic
lateral sclerosis and frontotemporal dementia (Lagier-Tourenne
et al., 2010; Lemmens et al., 2010). Recent studies demon-
strated that decreased expression or altered subcellular locali-
zation of TDP-43 resulted in reduced expression and altered
splicing of multiple mRNAs (Polymenidou et al., 2011; Tollervey
et al., 2011). These findings strongly implicate alterations in
RNA processing as a key event in several neurodegenerative
disorders. However, given the multiple functions of these pro-
teins, the pathogenic basis of these diseases remains unclear.
Recently, mutations in the gene encoding U4atac snRNA, a
component of the minor spliceosome that splices a restricted
(U12-dependent) class of introns found in less than 1%of human
genes, have been linked to the developmental disorder microce-
phalic osteodysplastic primordial dwarfism (Edery et al., 2011;
He et al., 2011). However, to date, mutations in the major spli-
ceosomal snRNA genes have not been associated with disease,
perhaps in part due to their ubiquitous expression and essential
function. Furthermore, unlike the U4atac gene, the snRNAs of
the major spliceosome are encoded by multiple genes and
pseudogenes in metazoans (Marz et al., 2008), suggesting that
these genes are highly redundant. Although differing in orga-
nization (e.g., U1 and U2 genes exist in large chromosomal
Figure 1. Progressive Granule Cell Degeneration in the NMF291/
Cerebellum
(A–F) Hematoxylin and eosin-stained sagittal sections of WT (+/+) and
NMF291/ cerebella. Cerebellar lobules are indicated by Roman numerals
(D). (E and F) Higher-magnification images of lobule IV/V from (C) and (D).
(G–J) Cleaved caspase-3 immunostaining (G and H) and TUNEL analysis
(I and J) of sections from 6-week-old cerebella. Sections were counterstained
with Hoechst 33342.
Scale bars, 500 mm (D), 50 mm (F), and 10 mm (J). See also Figure S1 and
Movie S1.clusters in the human genome, whereas other snRNA genes are
not clustered; Manser and Gesteland, 1982; Van Arsdell and
Weiner, 1984; Westin et al., 1984), sequence analysis of snRNA
genes suggests that they have apparently undergone concerted
evolution, i.e., members of gene families are identical or nearly so
within a species (Marz et al., 2008; Pavelitz et al., 1995).
However, the effect of polymorphisms in individual members of
these repetitive gene families on pre-mRNA splicing and the
extent to which the expression of single genes is independently
regulated are largely unknown.
Here, we report that a 5 nucleotide (nt) deletion in one member
of a cluster of mouse U2 snRNA genes causes neurodegenera-
tion and alternative splicing defects, including the retention of
small introns. Our study provides definitive evidence for the
causative role of splicing dysfunction in neurodegeneration and
a model to dissect the role of major spliceosomal snRNAs on
the regulation of mammalian pre-mRNA splicing.
RESULTS
Progressive Neurodegeneration in NMF291
Mutant Mice
The NMF (Neuroscience Mutagenesis Facility) 291mutation was
identified in a chemical mutagenesis screen for recessive muta-
tions that result in neurological phenotypes (Bult et al., 2004).
Mice homozygous for this mutation developed mild tremors by
8 weeks of age, which progressed to overt truncal ataxia by
12 weeks (see Movie S1 available online). At 4 weeks of age,
the brains of mutant mice appeared grossly normal (Figures
S1A–S1D). However, histological analysis revealed granule cells
with pyknotic nuclei in the mutant cerebellum beginning at
4 weeks of age (data not shown). Neuron loss was progressive,
and by 4 months of age, most granule cells had degenerated
(Figures 1A–1F). However, other cerebellar neurons, including
Purkinje cells, did not degenerate, even in aged mice (data not
shown). Although neuron death was most severe in the cere-
bellum, later-onset degeneration of granule cells in the dentate
gyrus region of the hippocampus was also observed (Figures
S1E–S1H).
To determine the nature of neuron death, immunostaining with
activated caspase-3 antibodies was performed on cerebellar
sections from 6-week-old mice. Many immunopositive granule
cells were observed in the mutant, but not the wild-type (WT)
cerebellum, suggesting that mutant neurons undergo apoptosis
(Figures 1G and 1H). Granule cell apoptosis was confirmed by
TUNEL (TdT-mediated dUTP nick end labeling) analysis (Figures
1I and 1J).
The NMF291 Mutation Deletes 5 nt in the Rnu2-8
U2 snRNA
The NMF291 mutation was initially localized to distal Chromo-
some 11 by a genome scan analysis of F2 mice using polymor-
phic microsatellite markers. Additional recombination mapping
narrowed the mutation interval to a 0.52 cM (0.34 Mb) region
between D11Mit200 and D11Mit199 containing eight protein-
coding genes (Figures 2A, 2B, and S2A). No coding sequence
polymorphisms between mutant and WT DNA were found in
these genes, nor did we observe differences in the expressionof the cerebellar transcripts of these genes between genotypes
(data not shown).
In addition to the protein-coding genes, a cluster of five U2
snRNA (Rnu2-6 to Rnu2-10) genes also resides in the NMF291
critical interval (Figure 2B). The RNAs encoded by these genes
are identical, except for a single nucleotide polymorphism in
Rnu2-6 (Figure S2B). Sequencing of mutant genomic DNA re-
vealed a 5 bp deletion between nt 30 and 34 (30AGUGU34) in
a highly conserved region of the Rnu2-8 transcription unit
(Figures 2C and 2D). This deletion removes the first 2 nt of
the U2 consensus branch site recognition sequence (BSRS)Cell 148, 296–308, January 20, 2012 ª2012 Elsevier Inc. 297
Figure 2. The NMF291 Mutation Is a 5 nt Deletion in a U2 snRNA Gene
(A) The NMF291 mutation was mapped to Chromosome 11 between D11Mit200 and D11Mit199 (values are in cM ± SEM).
(B) The NMF291 critical interval contains eight protein-coding genes (arrows) and five U2 snRNA genes (Rnu2-6–Rnu2-10; bars, top panel).
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Figure 3. The Expression of Rnu2-8 Is Temporally
and Spatially Regulated
(A and B) Total RNA from WT and NMF291/ (/) P30
cerebella was separated by denaturing acrylamide gels for
shorter (A) or longer (B) periods and subsequently
analyzed by northern blot analysis using an U2-specific
oligonucleotide probe. For loading controls, the gel was
stained with ethidium bromide (A, bottom), or the
membrane was rehybridized with a probe for 5S rRNA (B).
(C) RPA using increasing amounts of cerebellar RNA
(0.2–1 mg) from P30 WT and NMF291/mice. For loading
controls, RPA was also performed using a b-actin RNA
probe.
(D) RPA analysis of U2 snRNAs in various tissues taken
from P30 WT and NMF291/ mice.
(E) RPA analysis of U2 snRNAs in WT, NMF291+/ (+/),
and NMF291/ cerebella at different postnatal (P) ages
(days after birth). Cere., cerebellum; S.C., spinal cord.
See also Figure S3.(33GUAGUA38) and the 3 nt linker region (30AGU33) between
the BSRS and U2/U6 helix IA (Figures 2D and 2E) (Wahl et al.,
2009). The deletion was not observed in genomic DNA from
several other inbred stains, including C57BL6/J and 129S4/
SvJae, from which the F1 ES cells used for mutagenesis were
derived (data not shown).
Rnu2-8 Is Spatially and Temporally Regulated
To confirm that the U2 gene disrupted by theNMF291 deletion is
indeed expressed, we performed northern blot analysis and(C) Sequence chromatograms of WT (C57BL6/J) and mutant (NMF291/) Rnu2-8 genomic DNA amp
Asterisk (*) indicates nucleotides deleted in the mutant genome.
(D) Deleted nucleotides are evolutionarily conserved. Conserved nucleotides are boxed in black and
Nucleotideswith one ormoremismatches or absent across species are indicated in the consensus seq
The U2 BSRS, and the nucleotides in helices IA, II, and III, which base pair with U6 snRNA, are indic
sequence.
(E) The schematic of RNA:RNA interactions contributing to the first step of splicing. The 5 nt deletion
See also Figure S2.
Cell 148, 29RNase protection assays (RPAs) using cere-
bellar RNA isolated from P30 WT and mutant
mice. Total U2 snRNA levels were similar
between the WT and the NMF291/ cere-
bellum (Figure 3A), and both WT and the dele-
tion-containing Rnu2-8 RNAs were detected in
the mutant cerebellum (Figures 3B and 3C),
with the mutant transcript found at 78.9% ±
6.3% (n = 6) of the level of the WT U2 snRNA
(or 45% of total U2 levels). Similar analysis of
highly pure granule cell cultures demonstrated
that both WT and mutant U2 RNAs were ex-
pressed within the same cell type (data not
shown). Finally, immunoprecipitation experi-
ments using Y12 antibody, which precipitates
U snRNPs (Lerner et al., 1981), demonstrated
that the mutant U2 snRNAs were assembled
into mutant cerebellar U2 snRNPs (Figures
S3A and S3B), consistent with previous reportsthat the free snRNA pool is relatively very small and unstable
(Sauterer et al., 1988).
Mammalian U2 snRNAs, like other U snRNAs, are believed to
be ubiquitously and highly expressed (Egloff et al., 2008; Hernan-
dez, 2001). However, neurodegeneration in NMF291/ mice
was very distinct, with profound neuron loss occurring within
the cerebellum beginning at P30. To determine if expression of
mutant Rnu2-8 correlates with the specificity of pathological
changes, we performed RPA and northern blot assays using
neuronal and non-neuronal tissues from the P30 WT andlified using unique primers outside of the transcription unit.
indicated in uppercase letters in the consensus sequence.
uence in lowercase letters or with an asterisk, respectively.
ated. Nucleotides are numbered according to the mouse
in Rnu2-8 is highlighted in red.
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Figure 4. Mutant Rnu2-8 Acts in a Dosage-Dependent Fashion on
Neuron Survival
(A–F) Hematoxylin and eosin-stained sagittal sections of NMF291+/ and WT
(+/+) cerebella. (E and F) Higher-magnification images of lobule IV/V from (C)
and (D).
(G) The 1.5 kb DNA fragment, containing the transcription unit of the mutant
Rnu2-8 and its 50 and 30 flanking sequences, used for pronuclear injection.
300 Cell 148, 296–308, January 20, 2012 ª2012 Elsevier Inc.homozygous mutant mice (Figures 3D and S3C). Surprisingly,
mutant Rnu2-8 was differentially expressed between tissues,
with highest levels observed in the cerebellum. Furthermore,
mutant Rnu2-8 expression was also temporally regulated in the
postnatal cerebellum. Mutant U2 RNAs comprised 20%–
25% of the total U2 RNA levels in the P10 and P20 NMF291/
cerebellum but rose to 45% of the total level at P30 (Figures
3E, S3D, and S3E). This increase was maintained at P40 but
dropped slightly at P60, likely due to neuron loss in the mutant
cerebellum. This temporal regulation of expression was also
observed in heterozygous mice, where amounts of mutant U2
RNA were approximately half of that observed in homozygous
mice (Figures 3E and S3E). Together, these data suggest that
mammalian U2 snRNAs display previously unsuspected
temporal and spatial variation with the expression of mutant
Rnu2-8 correlating with the onset and specificity of neurodegen-
eration in the NMF291/ mouse.
Mutant Rnu2-8 Induces Neurodegeneration
in a Dosage-Dependent Manner
Although mice homozygous for the NMF291 mutation were orig-
inally ascertained in our screen, the site of the Rnu2-8 deletion,
the multicopy nature of the U2 genes, and the expression of
WT U2 snRNAs in the mutant cerebellum suggested that this
mutation might act in a gene dosage-dependent fashion. To
investigate this possibility, we performed histological analysis
of the cerebellum of NMF291+/ mice. Apoptotic granule cells
were observed in the cerebellum of 1-month-old and older
NMF291+/ mice, but the number of dying neurons was consid-
erably reduced compared to that observed in homozygous
NMF291 mice (data not shown). Differences in the overall
size of the NMF291+/ cerebellum were not obvious until mice
were close to 2 years of age, when mild tremors were apparent,
and histological analysis revealed that many granule cells had
degenerated (Figures 4A–4F).
To further test the mechanism of the Rnu2-8 mutation, we
generated mice transgenic for a 1.5 kb genomic DNA fragment
containing the mutant Rnu2-8 transcriptional unit and the basal
regulatory elements necessary for U2 transcription and process-
ing (Figure 4G) (Egloff et al., 2008; Hernandez, 2001). Mice from
one transgenic line (Tg-MuU2) expressed mutant Rnu2-8 in the
cerebellum, and expression was temporally and spatially regu-
lated similar to that observed in NMF291/ mice (Figures 4H–
4J and S4A). Like NMF291/ mice, hemizygous mice from
this line developed pronounced ataxia by 12 weeks of age
(data not shown). Histological analysis revealed dying granule
cells in the cerebellum of 1-month-old transgenic mice, and by
3 months of age, most granule cells had died, similar to the(H) RPA analysis of cerebellar RNA from P30 WT, NMF291+/, NMF291/
mice, and mice hemizygous for the mutant Rnu2-8 transgene (Tg).
(I) RPA analysis of cerebellar RNA from P20, P30, and P40 NMF291/ mice
and mice hemizygous for the transgene (Tg).
(J) RPA analysis of tissues from P30 NMF291/ and hemizygous Tg-MuU2
mice. Note that the NMF291/ cerebellar lane was run on a separate gel.
(K and L) Hematoxylin and eosin-stained sagittal sections of Tg-MuU2 cere-
bella. DES, distal sequence element; PES, proximal sequence element.
Scale bars, 500 mm (D and L) and 50 mm (F). See also Figure S4.
Figure 5. Transgenic Expression of WT U2 snRNAs Partially
Rescues the NMF291/ Phenotype
(A) Schematic of the RP23-268K4 BAC, containing three snRNA genes (Rnu2-
8, red bar; Rnu2-9 and -10, blue bars), used for transgenesis.
(B) RPA of cerebellar RNA from 1-month-old WT (+/+) or NMF291/ (/)
mice with or without the BAC transgene (RP23-268K4).
(C–F) Hematoxylin and eosin-stained sagittal sections of WT (+/+), RP23-
268K4 (Tg-268K4), NMF291/, and Tg-268K4; / cerebella.
Scale bar, 500 mm (F). See also Figure S5.time course of neuron death inNMF291/mice (Figures 4K and
4L; data not shown). As observed in NMF291/ mice, neuron
loss in the dentate gyrus was observed in 3-month-old trans-
genic mice (Figures S4B and S4C).
If the severity of neurodegeneration is indeed dependent on
the ratio of mutant to WT snRNAs, then the complementary
experiment in which an increase in expression of WT U2 RNA
on the NMF291/ background should lead to attenuation of
pathology. To test this hypothesis, we generated a transgenic
mouse line carrying a BAC (bacterial artificial chromosome
RP23-268K4) containing Rnu2-8 and two other U2 genes
(Rnu2-9 and -10; Figure 5A). This line was crossed to NMF291
mice to generate NMF291/ mice carrying the BAC transgene.
The percentage of mutant/total U2 snRNA was reduced in thecerebellum of Tg-268K4; NMF291/ and Tg-268K4;
NMF291+/ mice relative to that observed in the cerebellum of
age-matched NMF291/ and NMF291+/ mice (Figures 5B,
S5A, and S5B). Neurodegeneration was also decreased in the
cerebellum of 3-month-old Tg-268K4; NMF291/ mice relative
to that of age-matched NMF291/ mice (Figures 5C–5F).
Surprisingly, when mutant U2 RNAs represented 17% of total
U2 levels, little granule cell loss was observed in aged Tg-
268K4; NMF291+/ mice (Figures S5C–S5F). When the
percentage of mutant/total U2 RNA increased to 25% as
observed in the NMF291+/ cerebellum, neurodegeneration
was slowly progressive (Figures 4A–4F). However, when this
percentage reached 45% (as in the P30 NMF291/ and Tg-
MuU2 cerebellum), rapid granule neuron loss was observed
(Figures 1C and 4L). Taken together, our data demonstrate
that the expression of the mutant Rnu2-8 gene is sufficient to
induce granule cell death even in the presence of WT U2 expres-
sion, and the extent of neuron loss is dependent on the expres-
sion level of the mutant U2 snRNAs relative to that of the WT U2
snRNA.
Expression of the Mutant U2 snRNA Decreases
Splicing Efficiency
The central role of U2 snRNA in pre-mRNA splicing suggested
that abnormalities in this process underlie neurodegeneration
in NMF291/ mice. To study the impact of the mutant Rnu2-8
on pre-mRNA splicing, we employed a previously reported
splicing reporter construct, TN24 (ISS+), which encodes both
b-galactosidase and luciferase separated by an exon-intron-
exon cassette (Kollmus et al., 1996; Nasim et al., 2002). Although
b-galactosidase is constitutively expressed from this plasmid,
luciferase is only expressed when accurate splicing occurs
between the adenovirus 50 exon and the alternatively spliced
SK exon of human Tpm3 (see diagram in Figure 6C).
HEK293T cells were transfected with ISS+ alone, or cotrans-
fected with the reporter and a 1.5 kb genomic DNA fragment
containing the WT or the mutant (D5nt) U2 transcription unit
(Figures 6A–6C). As controls, cells were cotransfected with the
reporter and a plasmid encoding the RNA-binding protein
hnRNPG, which has been shown to silence splicing of this
exon-intron-exon cassette via binding of the 25 bp intronic-
splicing silencer (ISS) (Nasim et al., 2002). Transfection of WT
Rnu2-8 did not have a significant effect on reporter splicing as
determined by the ratio of luciferase/b-galactosidase activity or
by RT-PCR (Figure 6C). However, transfection of mutant Rnu2-
8 led to a significant decrease (28%; p < 0.01) in the splicing effi-
ciency of the reporter compared to that of cells transfected with
reporter alone.
Similar experiments were performed using the same reporter
lacking the 25 bp ISS (ISS) (Nasim et al., 2002) (Figure 6D). In
agreement with the role of the ISS sequence in splicing silencing,
we observed a 4- to 5-fold increase in splicing of this reporter
over that of the reporter containing the ISS sequence. As previ-
ously shown (Nasim et al., 2002), the inhibitory effect of hnRNPG
expression on ISS reporter splicing was greatly reduced
(Figure 6D). As observed for the ISS+ reporter, splicing of the
ISS reporter was not changed by expression of the WT U2.
However, in contrast to the attenuation of ISS+ reporter splicingCell 148, 296–308, January 20, 2012 ª2012 Elsevier Inc. 301
Figure 6. Mutant Rnu2-8 Selectively Decreases
Splicing Efficiency of Introns
(A) The sequences of WT and deletion (D) U2 constructs
used for cell transfection experiments.
(B) RPA analysis of RNA from mock-transfected HEK293T
cells or cells transfected with WT or DU2 plasmids.
(C and D) HEK293T cells were transfected with the ISS+
splicing reporter (C) or the ISS splicing reporter (D), or
cotransfected with WT or DU2 constructs as indicated.
The splicing of pBPLUGA parental vector is shown in (C)
as a control, and the splicing of the ISS+ reporter is shown
in (D) as a reference. The splicing efficiency of the
reporters was measured by luciferase/b-Gal (b-galacto-
sidase) activity (top panels in C and D) and confirmed by
RT-PCR (bottom panels). Values represent mean ± SEM,
n = 3; *p < 0.01; one-way ANOVA. Asterisk (*) and arrows in
reporter diagrams denote stop codons and RT-PCR
primers, respectively.
(E) A diagram of the 30 region of the L1CAM gene. Asterisk
(*) denotes stop codon. Arrows indicate RT-PCR primers.
(F) RT-PCR was performed on WT (+/+) and NMF291/
(/) cerebellar cDNA at indicated ages.
(G and H) HEK293T cells were transfected with L1CAM
exon 27-intron 27-exon 28 (G) and exon 28-intron 28-exon
29 (H) splicing reporters with or without WT or DU2
constructs as indicated. Splicing of these reporters was
analyzed as described above in (C) and (D). As references,
the spliced RT-PCR products of exon 27-intron 27-exon
28 reporter and the unspliced PCR product amplified from
the exon 28-intron 28-exon 29 reporter plasmid (DNA) are
also shown in (H). Values represent mean ± SEM, n = 3;
*p < 0.01; one-way ANOVA. Asterisks (*) in reporter
diagrams denote stop codons.
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by expression of the mutant U2 construct, expression of
the mutant U2 did not significantly affect splicing of the ISS
reporter. These results suggest that alterations in splicing effi-
ciency mediated by the expression of the mutant U2 snRNA
may be dependent on the presence of splicing regulatory
sequences.
The presence of intronic or exonic splicing regulatory
sequences often accompanies alternative splicing of pre-
mRNA (Black, 2003); thus, we initially analyzed several alterna-
tive-splicing events that were previously reported to occur in
the human cerebellum (Wang et al., 2008). Of the 20 alternative
splicing events, including 1 in the neural cell adhesion molecule
L1 (L1CAM), 4 displayed obvious changes in relative isoform
expression between the WT and NMF291/ cerebellum (data
not shown). PCR amplification of the distal exons of the
L1CAM transcript from WT cerebellar RNA generated two iso-
forms: the major form containing exons 27-28-29, and a minor
isoform that retains the 95 bp intron located between exons 27
and 28 (Figures 6E and 6F). Coincident with the decrease of
the fully spliced isoform, the abundance of the intron 27-contain-
ing isoform was increased in mutant cerebellar RNA. Interest-
ingly, these alterations in splicing were most dramatic in the
P30 and P40 cerebellum, demonstrating that the change in the
ratio of splicing variants was temporally regulated in a manner
coincident with expression of the mutant U2 snRNA.
To directly evaluate the effects of the mutant U2 on splicing of
intron 27, we generated L1CAM splicing reporters. A cassette
containing exon 27, the alternatively spliced intron 27, and
exon 28, or a cassette with exon 28, the constitutively spliced
intron 28, and exon 29 were cloned into the pBPLUGA plasmid
(Figures 6G and 6H). These plasmids were cotransfected into
HEK293T cells with theWT or mutant Rnu2-8 plasmid. Transfec-
tion of the intron 27-containing reporter resulted in both spliced
and unspliced transcripts as evidenced by RT-PCR (Figure 6G).
In contrast only spliced transcripts were observed in cells trans-
fected with the intron 28-containing reporter, and luciferase/
b-galactosidase activity was increased accordingly (Figure 6H).
Overexpression of the WT U2 had no effect on splicing of either
reporter. However, in agreement with our in vivo data, expres-
sion of mutant Rnu2-8 caused a decrease in splicing efficiency
(34%; p < 0.01) of intron 27, but not of intron 28, the splicing
efficiency of which was increased for unknown reasons (Figures
6G and 6H). These reporter data confirm that expression of the
mutant U2 disrupts splicing of select introns.
Deletion of the U2/U6 Helix IA Linker Is Sufficient
to Disrupt Splicing
The 5 nt deletion in Rnu2-8 removes 2 nt of the BSRS, which
recognizes and forms a duplex with the intronic branch site
(BS) of the pre-mRNA that is important for the spliceosome
assembly and the first catalytic step of splicing (Wahl et al.,
2009). In addition, the NMF291 deletion removes the 3 nt linker
between the BSRS and the sequence that forms the U2/U6 helix
IA. The distance between these two sequences has been shown
to change splicing kinetics in yeast (McGrail et al., 2006; Ryan
and Abelson, 2002; Smith et al., 2009). To further understand
the underlying mechanism of mutant Rnu2-8-induced splicing
defects, we created a series of U2 deletion plasmids: D6, inwhich the entire BSRS was deleted; D3, in which the linker
sequence between BSRS and U2/U6 helix IA was deleted; and
D9, in which both the entire BSRS and the linker were deleted
(Figure 6A).
Experiments in yeast demonstrated that mutations in U2
snRNA, which disrupt the duplex formation between the BSRS
and the BS, inhibit spliceosome assembly and result in the
degradation of these RNAs (Smith et al., 2009). In agreement
with these studies, we consistently observed lower expression
levels of D6 and D9 Rnu2-8 RNAs, both of which lack the
BSRS, compared to that observed for the WT, D5 (the NMF291
mutant form), and D3 Rnu2-8 RNAs in transfected cells (Fig-
ure 6B). Cotransfection of the D6 or the D9 plasmid with the
ISS+ reporter did not affect reporter splicing (Figure 6C).
However, expression of theD3 construct significantly decreased
(24%; p < 0.01) splicing of the ISS+ reporter, closely mimicking
the repression of splicing that was observed when D5 Rnu2-8
was cotransfected with the reporter. Also as observed with co-
transfection of D5 Rnu2-8, expression of D3 construct had no
effect on splicing of ISS splicing reporter (Figure 6D).
Similarly, expression of the D3 Rnu2-8 plasmid was sufficient
to reduce splicing (13%; p < 0.01) of intron 27 from the L1CAM
intron 27-containing splicing reporter, although not as efficiently
as cotransfection of the reporter withD5Rnu2-8, suggesting that
the deletion of 2 nt of the BSRS may also contribute to the D5
effect on splicing (Figure 6G). Cotransfection of the D3 plasmid
with the intron 28-containing reporter again led to an increase
rather than decrease of splicing, as did expression of the D6
and D9 plasmids (Figure 6H). Our data suggest that expression
of a U2 snRNA with either the NMF291-associated 5 nt deletion
or lacking the linker sequence between the BSRS and the U2/U6
helix IA disrupts select intron splicing.
Abnormal Alternative Splicing in the NMF291
Mutant Cerebellum
To analyze alternative splicing in the NMF291 mutant cere-
bellum, exon expression was examined by Affymetrix mouse
exon 1.0 ST microarrays. Microarrays were hybridized with
RNA from three WT and three NMF291/ cerebella isolated at
P30, a timewhen themutant U2 RNA is expressed at peak levels,
but few neurons have degenerated (Figures S1A–S1D, 3E, and
S3E). A total of 123 genes were differentially expressed between
the WT and mutant cerebellum, as demonstrated by analysis
of signal across all probe clusters for a gene (fold changeR1.5;
p < 0.05) (Table S1A). Differential expression of most (78%) of
these genes was relatively low (1.5- to 2-fold), suggesting that
overall gene expression was not dramatically altered in the P30
mutant cerebellum.
Paired analysis of the exon splicing index (SI), which was
calculated by normalizing exon expression to gene level expres-
sion (Clark et al., 2007; de la Grange et al., 2010), revealed that
the expression of 206 exons in 178 genes was differentially ex-
pressed between the WT and mutant cerebellum (SI fold change
R1.5; p < 0.05) (Table S1B). These exons were compared to the
comprehensive list of known human and mouse splice variants
in the FAST DB database (de la Grange et al., 2007), and 146
(71%) events, representing all major types of alternative splicing
patterns, were previously annotated as alternatively splicedCell 148, 296–308, January 20, 2012 ª2012 Elsevier Inc. 303
(Table S1B; Figure 7A). To validate our exon array results,
RT-PCR was performed using cerebellar cDNA from four inde-
pendent mice of each genotype. Of these events, 92% (12 of
13) were validated as differentially spliced between the WT and
mutant cerebellum (Figure S6A; data not shown).
Interestingly, 14% of the differentially spliced events detected
by exon array analysis were annotated as alternatively spliced
introns, although introns normally represent a very minor (1%–
3%) class of alternative splicing events (Chacko and Rangana-
than, 2009; de la Grange et al., 2010; Wang et al., 2008). To
examine this more closely and to expand our exon array results,
we performed RNA-Seq analysis. Libraries were prepared from
cerebellar mRNA from three P30 mutant and two P30 WT mice
and sequenced. The resulting reads were aligned to the mouse
genome reference sequence via SpliceMap (http://www.
stanford.edu/group/wonglab/SpliceMap/), an algorithm that
maps exon-exon junctions without relying on previous exon
annotations for recovering the splicing junctions (Au et al.,
2010). A total of 53.48 ± 6.35 3 106 reads per sample were
uniquely mapped to the mouse genome, and 61.23% ± 1.18%,
20.80% ± 1.54%, and 6.20% ± 0.19% of these reads uniquely
mapped to exons, introns, and splice junctions, respectively
(Table S1C).
To identify alternative splicing pattern changes between the
WT and NMF291/ cerebellum, splicing junction reads were
extracted and normalized for isoform expression to generate
the Relative Junction Index (RJI) (Figure S6). Comparison of
the RJI between the two genotypes identified 1,636 junctions
that were differentially expressed (RJI ratioR 2.0; p < 0.05; Table
S1D). In addition, 52 and 1,137 junction reads that were present
only in the WT and mutant data sets, respectively, indicated that
many splicing variants in the mutant cerebellum were not
present, or present at a very low levels, in the WT cerebellum
(Table S1E). As described above, RT-PCR using WT and mutant
cerebellar cDNA was performed to test differential splicing of
junctions. A total of 20 of 20 junctions that were originally identi-
fied in both genotypes and 20 of 21 (95%) of the junctions iden-
tified only in 1 genotype were validated (Figures S6B and S6C;
data not shown).
To examine global abnormalities in splicing of introns in the
mutant cerebellum, we calculated the Relative Intron retention
Index (RII) from our WT and mutant RNA-Seq data sets (Fig-
ure S6). Comparison of WT and mutant RIIs indicated that
3,978 introns were retained at higher levels in the mutant cere-
bellum (RII ratioR 2; p < 0.05, Figure 7B; Table S1F), including
intron 27 of L1CAM (RII ratio = 3.55; p = 0.0012). In contrast,
we identified only 362 introns that were retained at higher levels
in the WT cerebellum (RII ratioR 2; p < 0.05). To check the val-
idity of our analysis, we performed RT-PCR on 23 introns that
were present at higher levels in the mutant transcriptome by
RNA-Seq, and all were validated (Figures S6D and S6E; data
not shown). Furthermore, 19 of 23 (82.61%) of these introns,
like intron 27 of LICAM, and 5 of 7 RT-PCR-validated introns
identified by exon array, were also present in WT cerebellum
as aminor isoform (Figures S6A and S6D). These results indicate
that these introns represent alternative splicing events and are
likely to be suboptimal pre-mRNA substrates even in presence
of the WT spliceosome. Previous studies have shown that small304 Cell 148, 296–308, January 20, 2012 ª2012 Elsevier Inc.introns are prone to being retained in human and mouse tran-
scripts in physiological conditions (Sakabe and de Souza,
2007). These prompted us to check the size distribution of the
intron retention events identified by RNA-Seq. Indeed, 30.62%
of the retained introns in the mutant cerebellum were less than
100 bp, which largely differs from the size distribution of introns
in the mouse genome (RefSeq; 5.31% < 100 bp) or those signif-
icantly retained in the WT cerebellum (3.31% < 100 bp) (Fig-
ure 7C). As expected, differences in splicing of small introns
removed by the U12-dependent minor spliceosome were not
observed in the mutant cerebellum (Figure S6F). Thus, both
exon array and RNA-Seq analysis demonstrated that a group
of alternative splicing events, including the splicing of small
introns, was altered in the NMF291/ cerebellum.
To check the overlap of our exon array and RNA-Seq analysis,
we compared intron retention events (Table S1H). Of these
events, 96.4% (27 of 28) detected by exon array displayed differ-
ences in the same direction in RNA-Seq data, although only
46.4% (13 of 28) passed our stringent threshold set for RNA-
Seq analysis. Although differential events in other splicing event
categories ascertained by both analyses were clearly validated
by RT-PCR, little overlap was observed in the data sets, likely
due to the different experimental and analysis parameters used
in the two methods (see Extended Experimental Procedures).
The role of U2 snRNA as a basal component of the spliceo-
some would predict that splicing of transcripts encoding
proteins across many functional classes would be disrupted in
the mutant cerebellum. Indeed, splicing alterations between
the WT and mutant cerebellum occur in genes with many pre-
dicted cellular roles (Tables S1B and S1D–S1F). However,
Gene Ontology (GO) analysis of the differentially expressed junc-
tions and spliced introns detected by RNA-Seq and exon array
analysis revealed that genes annotated to GO terms of nucleo-
plasm (GO:0005654) were significantly enriched, as were those
annotated to ribonucleotide binding (GO:0032553) (Table S1G).
Interestingly, after these two functional clusters, the most signif-
icantly enriched genes in the differentially spliced intron data set
were annotated to mRNA processing (GO:0006397), including
those annotated to the spliceosomal complex (GO:0005681)
(Figure 7D; Table S1G). Differentially expressed exons and
genes also showed significant enrichment for mRNA processing,
although at higher p values.
DISCUSSION
We demonstrate that a mutation in one of the multicopy mouse
U2 snRNA genes causes defects in pre-mRNA splicing, leading
to neurodegeneration. U2 snRNAs play an essential role in
formation of the catalytically active spliceosome by base pairing
with both the intron branch point and the U6 snRNA (Wahl et al.,
2009). Expression of the mutant U2 snRNA alters pre-mRNA
splicing at selective splice sites that are often associated with
alternative splicing, demonstrating that U-snRNA dysfunction,
like downregulation of core spliceosomal proteins, can influence
splice site choice (Corioni et al., 2011; Park et al., 2004; Saltzman
et al., 2011; Shaw et al., 2007).
One of the main pathological features of the NMF291/ cere-
bellum is the increased retention of small introns, which likely
Figure 7. Global Splicing Abnormalities in the NMF291/ Cerebellum
(A) Types of alternative splicing events identified by exon array analysis as differentially spliced between theWT and theNMF291/ cerebellum. A3SS, alternative
30 splice site; A5SS, alternative 50 splice site; AFE, alternative first exon; ALE, alternative last exon; MXE, mutually exclusive exon; T3UTR, truncated 30UTR.
(B) The log of the mutant/WT IRI generated by RNA-Seq analysis plotted against the log of the intron length (bp).
(C) Significantly retained introns in the cerebellum of NMF291/ or WT mice, or RefSeq introns were grouped by length and plotted as a percentage of the total
introns.
(D) GO analysis of genes annotated to the pre-mRNA splicing GO term were significantly enriched in the differentially spliced exons (Diff. junctions) and introns
(Diff. introns) identified by RNA-Seq, and differentially spliced exons (Diff. exons) and differentially expressed genes (Diff. genes) identified by exon array.
Percentage is the number of genes (the numerator in parentheses) annotated to the GO term divided by the total number of inputted genes (the denominator in
parentheses). Fold enrichment is the magnitude of enrichment of input genes relative to all mouse genes annotated to pre-mRNA splicing. The p value indicates
the significance of gene-term enrichment with a modified Fisher’s exact test.
(E) The working model for our findings. The splicing status and biological consequences of expression of WT (blue) and NMF291mutant (red) U2 snRNAs in WT
and NMF291/ neurons are shown. Our in vivo and in vitro data suggest that expression of mutant U2 snRNA disrupts splicing at many suboptimal or weaker
splice sites, including some of those used in alternative splicing. These changes in alternative splicing may be further amplified by altered splicing of
RNA-processing factors caused directly by mutant U2 snRNAs or by autoregulation.
See also Figure S6 and Tables S1A–S1H.
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represent unique spliceosomal substrates. Unlike splicing of
large introns, which is thought to first occur by pairing of splice
sites across the exon (‘‘exon definition’’), splicing of short
introns likely occurs by pairing of 50 and 30 splice sites across
the intron (‘‘intron definition’’) (Berget, 1995). Furthermore,
even under normal physiological conditions, many of the highly
retained introns in the mutant cerebellum are not fully spliced,
consistent with the observation that weak splicing sites often
flank small introns (Lim and Burge, 2001; Sakabe and de Souza,
2007). Given the disruption of short intron splicing and other
alternative splicing events, it is plausible that mutant U2 snRNPs
are fully functional on optimal, but not suboptimal, substrates
(Figure 7E).
Interestingly, we found that mRNA-processing genes were
significantly enriched among the alternative splicing events
differentially expressed between theWT andmutant cerebellum,
suggesting that neurons may utilize alternative splicing to regu-
late the function of proteins involved in RNA splicing and pro-
cessing in an effort to restore splicing homeostasis. Indeed,
studies have shown that a number of splicing regulators autore-
gulate their expression and activity via transcriptional feedback
loops and alternative splicing (Ni et al., 2007; Saltzman et al.,
2011;Wollerton et al., 2004). However, rather than reestablishing
homeostasis, these splicing alterations could in fact act to
amplify the amount of abnormal splicing and ultimately prove
deleterious. It will be intriguing to see whether the expression
level and/or alternative splicing status of these mRNA-process-
ing genes is also affected in SMA patients or ALS/FTD patients
with mutations in TDP-43 or FUS/TLS.
The ultimate cause of neuron death in themutant cerebellum is
unclear. Cell death could be caused by the generation of proteins
with altered function or by the production of RNAs containing
abnormal sequences, which could themselves be toxic as previ-
ously reported for trinucleotide repeat expansion diseases (Li
et al., 2008). Retained introns may also contribute to neuron
death by sequestering splicing regulators and/or other RNA
binding proteins. In addition, many of these introns likely harbor
premature translation termination codons (PTCs) that would be
predicted to trigger the nonsense-mediated mRNA-decay
(NMD) pathway. In addition to its role in degradation of abnormal
transcripts, NMD also regulates many natural PTC-containing
transcripts, including those involved in synaptic physiology and
cellular stress (Gardner, 2010; Giorgi et al., 2007). Enhanced
and/or prolonged NMD activation could overwhelm the NMD
pathway, causing dysregulation of natural NMD targets that
might be essential for cell survival, or itself cause cellular stress.
Finally, our data demonstrate the potential for disease-
causing mutations in multicopy genes. Although a single U2
gene is present in yeast, multiple copies of these genes exist in
higher organisms, each producing identical or nearly identical
products. Indeed, the region on human Chromosome 17p21
(homologous to the Rnu2-6 to Rnu2-10-containing region on
mouse Chromosome 11) also contains a cluster of stably in-
herited U2 genes that vary in copy number from 5 to 25 (Van
Arsdell and Weiner, 1984; Westin et al., 1984). In addition to
our findings of temporal and spatial regulation of a mouse U2
gene, developmental regulation of other snRNA genes, including
U2 snRNA genes, has been reported (Forbes et al., 1984; Lund306 Cell 148, 296–308, January 20, 2012 ª2012 Elsevier Inc.et al., 1985; Sierra-Montes et al., 2005; Stefanovic et al., 1991).
Furthermore, the developmental arrest associated with homozy-
gosity for a mutation in 1 of 12 C. elegans U1 genes raises the
possibility of differences in expression and/or function between
C. elegans U1 genes (Zahler et al., 2004). Whether individual
human U2s (or other multicopy genes) are differentially ex-
pressed during development, in different cell types, or even as
a result of pathogenic processes is unknown. However, the
potential for discrete regulation of individual members of multi-
gene families, combined with their potential for copy number
variation, increases the prospect of uncovering disease-causing
mutations in repetitive genes.
EXPERIMENTAL PROCEDURES
Mice
The NMF291mutant strain was derived from EMS-treated ES cells and a two-
generation mating scheme, as described previously (Munroe and Schimenti,
2009). Genetic mapping of the NMF291 mutation was performed using an
intersubspecific intercross (B6; 129 NMF291 3 CAST/Ei). The Jackson Labo-
ratory Animal Care and Use Committee approved all animal protocols.
Histology Analysis
Hematoxylin and eosin staining was performed on Bouin’s fixed tissue.
Cleaved Caspase-3 (Cell Signaling) immunostaining and TUNEL assays
(Roche) were performed as described previously (Zhao et al., 2005). At least
three mice of each genotype were used for all histological analyses.
RPA, Northern Blot Assay, and RT-PCR Assay
Total RNA was extracted by TRIzol (Invitrogen) and treated with DNase I (Am-
bion). RPA analysis was performed as suggested by the manufacturer’s
instructions (Ambion). For northern blots, total RNA was separated by 10%
denaturing polyacrylamide gel, and the membrane was hybridized with end-
labeled DNA oligo probes. RT-PCR was performed on random-primed
cDNA (Invitrogen). Primers used for RT-PCR are described in Table S2.
Density of bands in scanned X-ray films was determined by ImageQuant 5.2
software (Amersham).
Constructs, Cell Culture, Transfection, and Luciferase Assays
ThemutantRnu2-8DNA fragment used for generating transgenic mice and the
corresponding WT DNA fragment were cloned into pCR2.1-TOPO for expres-
sion of WT and mutant U2 snRNA in cultured cells. The D3, D6, and D9 U2
snRNA and ISS expression constructs were generated by site-directed
mutagenesis (Stratagene). Primers used for construct generation are
described in Table S2B. HEK293T cells were used for transient transfection
(Lipofectamine 2000; Invitrogen). Luciferase and b-galactosidase activities
(Promega) were measured in a multilabel counter 48 hr after transfection.
Statistical significance was determined by ANOVA analysis (SPSS).
Exon Array, RNA-Seq, and Functional GO Analysis
Data treatment of Mouse Exon 1.0 ST Arrays (Affymetrix) was done by the EA-
SANA analysis and the interface visualization system (GenoSplice Technology,
http://www.genosplice.com), which is based on the FAST DB annotations (de
la Grange et al., 2007). Probe selection and statistical analysis were preformed
as previously described (Clark et al., 2007; de la Grange et al., 2010). The GEO
(Gene Expression Omnibus) accession number for our exon array data is
GSE33069. For RNA-Seq, mRNA purification and DNA library preparation
were performed according to the manufacturer’s protocol (Illumina). The
library was sequenced on Illumina GAIIX using paired-end read strategy. For
de novo identification of junctions, the reads were inputted to SpliceMap
3.3.6 (Au et al., 2010) and aligned to the mouse reference genome. A work-
flow chart of our RNA-Seq analysis is shown in Figure S6G. RefSeq intron
length information was extracted fromUCSC. The GO analysis was conducted
by using DAVID bioinformatics resources 6.7 (Huang da et al., 2009). Primers
used for exon array and RNA-Seq validation experiments are described in
Table S2C.ACCESSION NUMBERS
Our exon array data have been deposited into the GEO. The GEO accession
number is GSE33069. The databank accession numbers for the Rnu2-6,
Rnu2-7, Rnu2-8, Rnu2-9, and Rnu2-10 sequences reported in this paper are
JN863957, JN863958, JN863956, JN863959, and JN863960, respectively.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, two tables, and one movie and can be found with this article online
at doi:10.1016/j.cell.2011.11.057.
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